Article information
Full text is only aviable in PDF
References
[1.]
G.S. Chuang, A. Martinez-Mir, A. Geyer, D.E. Engler, B. Glaser, P.B. Cserhalmi-Friedman, et al.
Germline fumarate hydratase mutations and evidence for a founder mutation underlying multiple cutaneous and uterine leiomyomata.
J Am Acad Dermatol, 52 (2005), pp. 410-416
[2.]
S. Badeloe, R.S. Bladergroen, M.F. Jonkman, N.P. Burrows, P.M. Steijlen, P. Poblete-Gutiérrez, et al.
Hereditary multiple cutaneous leiomyoma resulting from novel mutations in the fumarate hydratase gene.
J Dermatol Sci, 51 (2008), pp. 139-143
[3.]
G. Hayedeh, M. Fatemeh, R. Ahmadreza, A. Masoud, S. Ahmad.
Hereditary leiomyomatosis and renal cell carcinoma syndrome: A case report.
Dermatol Online J, 14 (2008), pp. 16
[4.]
S. Kohler.
Muscle adipose and cartilage neoplasms.
Dermatology, 2nd ed., pp. 1981-1983
[5.]
J.A. Thompson.
Therapy for painful cutaneous leiomyomas.
J Am Acad Dermatol, 13 (1985), pp. 865-867
[6.]
A.J. Chaves, J.M. Fernández-Recio, D. De Argila, I. Rodríguez-Nevado, M. Catalina.
Leiomioma cutáneo zosteriforme. Tratamiento satisfactorio con doxazosina oral.
Actas Dermosifiliogr, 98 (2007), pp. 494-496
[7.]
M. Onder, E. Adisen.
A new indication of botulinum toxin: Leiomyoma-related pain.
J Am Acad Dermatol, 60 (2009), pp. 325-328
Copyright © 2010. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
